Antimicrobial Peptides With Metal-Binding Motifs
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The rise of antibiotic-resistant bacteria, particularly carbapenem-resistant Enterobacteriaceae, and the formation of biofilms on medical devices pose a significant challenge due to the limited efficacy of standard antibiotics and the lack of approved anti-biofilm drugs, leading to chronic and refractory infections with high treatment costs and mortality.
Innovation Solution
Development of antimicrobial peptides with an amino-terminal Cu(II) and Ni(II) binding motif, such as the ATCUN motif, conjugated to the N-terminus of existing peptides to enhance their antimicrobial activity, which generates reactive oxygen species and degrades extracellular DNA within biofilms, thereby disrupting biofilm formation and increasing susceptibility to conventional antibiotics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If standard antibiotics are used to treat bacterial infections, then bacterial growth is inhibited, but antibiotic resistance develops and efficacy is limited
Solution Approach 1:
The patent modifies the chemical structure of antimicrobial peptides by incorporating metal-binding motifs (GGH, VIH, HRH) at the N-terminus, changing the peptide's binding parameters to metal ions (Cu2+, Ni2+) to enhance antimicrobial activity and overcome resistance mechanisms of standard antibiotics
Solution Approach 2:
The invention creates composite antimicrobial agents by combining peptide sequences with metal-binding capabilities, forming a hybrid system that integrates the peptide portion with metal ion coordination chemistry to achieve enhanced antimicrobial and antibiofilm activity
2Reliability
If naturally occurring antimicrobial peptides are used, then antimicrobial activity is achieved, but cytotoxicity and insufficient activity are problems
Solution Approach 1:
The patent introduces metal-binding motifs specifically at the N-terminus of the peptide, localizing the metal coordination function to a specific region while maintaining the peptide's overall structure and reducing cytotoxic effects through targeted modification
Solution Approach 2:
By modifying the N-terminal amino acid sequence to include metal-binding motifs, the patent changes the peptide's binding affinity and metal ion coordination parameters to enhance antimicrobial activity while maintaining biocompatibility
3Reliability
If biofilms are formed by bacteria, then protection from exogenous agents is achieved, but treatment becomes refractory and chronic infections occur
Solution Approach 1:
The metal-binding motifs in the peptides act as intermediaries that chelate metal ions (Cu2+, Ni2+) to generate reactive oxygen species, which serve as the active killing agents that penetrate and disrupt the biofilm protective matrix
Solution Approach 2:
The peptides utilize metal ion chelation to generate reactive oxygen species through oxidation reactions, creating strong oxidative stress that degrades biofilm extracellular polymeric substances and kills embedded bacteria, overcoming the protective barrier
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified peptides demonstrate enhanced antimicrobial activity against resistant bacteria, including carbapenem-resistant strains, with reduced hemolytic toxicity and improved survival rates in animal models, offering a potential alternative to traditional antibiotics and naturally occurring antimicrobial peptides.
Implementation Method 1
an amino-terminal Cu(II) and Ni(II) binding motif that is conjugated to the N-terminus of the peptide portion
Implementation Method 2
generates reactive oxygen species and degrades extracellular DNA within biofilms
Implementation Method 3
degrades extracellular DNA within biofilms, thereby disrupting biofilm formation
Data Source
AI summary
Provided herein are synthetic peptides with enhanced antimicrobial and antibiofilm characteristics, and are biocompatible with mammalian cellular systems. The disclosed synthetic antimicrobial moieties include a peptide portion and an amino-terminal Cu(II) and Ni(II) binding motif that is conjugated to the N-terminus of the peptide portion. Also provided are compositions comprising the synthetic peptides, as well as methods of treating a microbial infection or removing a biofilm using the peptides.

